Retrospective validation of coverage probability based simultaneous integrated nodal boost in locally advanced cervical cancer: a mono-institutional analysis.
Auteurs : Kedves A, Gulyban A, Glavak C, Toller G, Völgyi Z, Faour A, Bálint A, Petrási B, Rák T, Lakosi F Année : 2022 Journal : Acta Oncol
Radiomics software comparison using digital phantom and patient data: IBSI-compliance does not guarantee concordance of feature values.
Auteurs : Paquier Z, Chao SL, Acquisto A, Fenton C, Guiot T, Dhont J, Levillain H, Gulyban A, Bali MA, Reynaert N Année : 2022 Journal : Biomed Phys Eng Express
Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG
Auteurs : Dragan T, Van Gossum A, Duprez F, Lalami Y, Lefebvre Y, Mootassim-Billah S, Beauvois S, Gulyban A, Vandekerkhove C, Boegner P, Paesmans M, Ameye L, Digonnet A, Quiriny M, Dequanter D, Lipski S, Willemse E, Rodriguez A, Carlot S, Karaca Y, Lemort M, Emonts P, Al Wardi C, Van Gestel D Année : 2022 Journal : Trials
Triggered Imaging With Auto Beam Hold and Pre-/Posttreatment CBCT During Prostate SABR: Analysis of Time Efficiency, Target Coverage, and Normal Volume Changes.
Auteurs : Kisivan K, Antal G, Gulyban A, Glavak C, Laszlo Z, Kalincsak J, Gugyeras D, Jenei T, Csima M, Lakosi F Année : 2021 Journal : Pract Radiat Oncol
HDR brachytherapy boost using MR-only workflow for intermediate- and high-risk prostate cancer: 8-year results of a pilot study.
Auteurs : Lakosi F, Antal G, Pall J, Farkas A, Jenei T, Nagy D, Liptak J, Sipocz I, Pytel A, Csima M, Gulyban A, Toller G Année : 2021 Journal : Brachytherapy